Aligning You with Institutional Capital and Strategic Partnerships.
An elite advisory firm dedicated to redefining growth through bespoke capital solutions, transformative M&A strategies, and forward-thinking advisory services. With unparalleled market insights and a global reach, we craft opportunities that drive innovation, foster partnerships, and deliver enduring value for our clients
Track Record
Our Services
Capital Raising (Debt and Equity)
Structuring and executing tailored equity and debt capital raises, leveraging deep market relationships and strategic insights to secure funding for a variety of situations, including growth initiatives, acquisitions, recapitalizations, and strategic expansions, ensuring your capital structure is optimized for long-term success.
M&A Advisory
Providing end-to-end advisory services for both buy-side and sell-side transactions, including situations such as market consolidation, strategic acquisitions, divestitures, and cross-border deals. Our expertise covers target identification, valuation, due diligence, negotiation, and post-merger integration, ensuring that every transaction enhances shareholder value and aligns with your strategic objectives.
Strategic Advisory
Offering comprehensive strategic guidance on critical business decisions, including market entry and expansion strategies, corporate governance, risk management, and organizational transformation. Our advice is designed to align operations with your long-term vision, drive growth, and maximize enterprise value.
Deal Origination
We excel in uncovering and capitalizing on top-tier investment prospects across a range of industries and international markets. By utilizing comprehensive market knowledge and tailored analytics, we effectively bridge capital with innovative ventures and growth opportunities.
Capital Raising (Debt and Equity)
Structuring and executing tailored equity and debt capital raises, leveraging deep market relationships and strategic insights to secure funding for a variety of situations, including growth initiatives, acquisitions, recapitalizations, and strategic expansions, ensuring your capital structure is optimized for long-term success.
M&A Advisory
Providing end-to-end advisory services for both buy-side and sell-side transactions, including situations such as market consolidation, strategic acquisitions, divestitures, and cross-border deals. Our expertise covers target identification, valuation, due diligence, negotiation, and post-merger integration, ensuring that every transaction enhances shareholder value and aligns with your strategic objectives.
Strategic Advisory
Offering comprehensive strategic guidance on critical business decisions, including market entry and expansion strategies, corporate governance, risk management, and organizational transformation. Our advice is designed to align operations with your long-term vision, drive growth, and maximize enterprise value.
Deal Origination
We excel in uncovering and capitalizing on top-tier investment prospects across a range of industries and international markets. By utilizing comprehensive market knowledge and tailored analytics, we effectively bridge capital with innovative ventures and growth opportunities.
Track Record
About Rivers Capital Partners
Rivers Capital Partners is a trusted advisory firm specializing in capital raising, mergers & acquisitions, debt advisory, and strategic partnerships.
We draw on extensive expertise in capital markets and proprietary insights to deliver tailored financial solutions. Our innovative approach combines deep industry knowledge with advanced methodologies, offering clients highly customized and optimized transaction strategies that go beyond traditional advisory services.
Recent Transactions
Vancouver based Biotech
Raised $15M convertible note with a San Francisco VC.
Houston based Biopharma
Raised $28M in equity with a Singaporean family office and a Chicago VC
Malasyan Semiconductor Manufacturer
$32M equity raised with a Shanghai-based group.
New York based Investment Bank
Partnered with a New York-based investment bank to close a $14M oncology practice acquisition with $10M in debt and $4M in equity, and a $29M medical technology firm acquisition with $20M in debt and $9M in equity.